Skip to main content

Genomics and Hematologic Malignancies: Beyond the Philadelphia Chromosome

Held in conjunction with the Oncology Nursing Society’s 46th Annual Congress

Click Here to Participate 

Format: Noninteractive recorded webinar
1.5 CE Credits Available Until: December 30, 2022



It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Healthcare providers must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.

Target Audience

Nurse practitioners, nurses, social workers and other healthcare providers involved in the care of patients with hematologic malignancies.

Course Content Level for Social Workers —  All levels


Learning Objectives

After completing this activity, participants should be better able to:

  • Discuss foundational genomic concepts (DNA, gene, chromosome, somatic and germline genomic variants)
  • Discuss and define biomarkers and biomarker testing
  • Identify appropriate biomarker (genomic) testing for hematologic cancers across the care continuum (diagnosis, prognosis, treatment, disease monitoring)
  • Describe the role of the nurse, APRN, and others on the healthcare team in preparing patients and caregivers for biomarker testing, including access and financial implications
  • Identify resources to educate and support patients and caregivers regarding biomarker testing



Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC
Associate Professor and Program Director
Marcella Niehoff School of Nursing
Loyola University Chicago
Maywood, IL

RN3 (Staff/Charge Nurse)
Inpatient Hematology/HSCT unit
Rush University Medical Center
Assistant Professor
Health Systems & Adult Health Nursing
Marcella Niehoff School of Nursing
Loyola University Chicago
Maywood, IL


Continuing Education Information

Registered Nursing Designation 
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

Social Work Designation 
The Leukemia & Lymphoma Society (LLS), Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2020-12/10/2023. Social workers completing this course receive 1.5 clinical continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.5 CE clinical contact hour for this activity.

All continuing education credits are provided free of charge.

Participants must attend the free webinar in its entirety, submit the online evaluation form, and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be generated as a PDF online.

To view system requirements please visit 



This program is provided by The Leukemia & Lymphoma Society.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact


< Back to Continuing Education